One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?

Surgery

Volumn 146, Issue 6, 2009, Pages 998-1005

  Shifrin, Alexander L ^a   Xenachis, Cristina ^b   Fay, Angela ^a   Matulewicz, Theodore J ^a   Kuo, Yen Hong ^a   Vernick, Jerome J ^a  

^a JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^b Downtown Osteoporosis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ANTICIPATION, GENETIC; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; ITALY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE; PENETRANCE; PHEOCHROMOCYTOMA; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RETROSPECTIVE STUDIES; SYNDROME; THYROID NEOPLASMS;

EID: 70549098157     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.021     Document Type: Article

References (25)

1. Castellone M.D., and Santoro M. Dysregulated RET signaling in thyroid cancer. Endocrinol Metab Clin North Am 37 (2008) 363-374
2. Takahashi M., Ritz J., and Cooper G.M. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42 (1985) 581-588
3. Donis-Keller H., Dou S., Chi D., Carlson K.M., Toshima K., Lairmore T.C., et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2 (1993) 851-856
4. Mulligan L.M., Kwok J.B., Healey C.S., Elsdon M.J., Eng C., Gardner E., et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 (1993) 458-460
5. Eng C., Smith D.P., Mulligan L.M., Nagai M.A., Healey C.S., Ponder M.A., et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3 (1994) 237-241
6. Carlson K.M., Dou S., Chi D., Scavarda N., Toshima K., Jackson C.E., et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A 91 (1994) 1579-1583
7. Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276 (1996) 1575-1579
8. Brandi M.L., Gagel R.F., Angeli A., Bilezikian J.P., Beck-Peccoz P., Bordi C., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86 (2001) 5658-5671
9. Fink M., Weinhüsel A., Niederle B., and Haas O.A. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA).". Int J Cancer 69 (1996) 312-316
10. Learoyd D.L., Gosnell J., Elston M.S., Saurine T.J., Richardson A.L., Delbridge L.W., et al. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clin Endocrinol (Oxf) 63 (2005) 636-641
11. Gibelin H., Bezieau S., Misso C., Bouin-Pineau M.H., Maréchaud R., and Kraimps J.L. Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A. Br J Surg 91 (2004) 1458-1459
12. Pinna G., Orgiana G., Riola A., Ghiani M., Lai M.L., Carcassi C., et al. RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype. Thyroid 17 (2007) 101-104
13. Feldman G.L., Edmonds M.W., Ainsworth P.J., Schuffenecker I., Lenoir G.M., Saxe A.W., et al. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG->ATG) mutation. Surgery 128 (2000) 93-98
14. Frohnauer M.K., and Decker R.A. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?. Surgery 128 (2000) 1052-1057
15. Decker R., and Peacock M. Update on the profile of multiple endocrine neoplasia type 2a RET mutations. Cancer Supplements 80 (1997) 557-568
16. Fattoruso O., Quadro L., Libroia A., Verga U., Lupoli G., Cascone E., et al. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma. Hum Mutat Suppl 1 (1998) S167-S171
17. Brauckhoff M., Gimm O., Hinze R., Ukkat J., Brauckhoff K., and Dralle H. Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation. Thyroid 12 (2002) 557-561
18. Dionigi G., Castano P., Bertolini V., Boni L., Rovera F., Tanda M.L., et al. Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Reports 1 (2007) 133
19. Papi G., Corrado S., Pomponi M.G., Carapezzi C., Cesinaro A., and LiVolsi V.A. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation. Endocr Pathol 14 (2003) 269-276
20. Foppiani L., Forzano F., Ceccherini I., Bruno W., Ghiorzo P., Caroli F., et al. Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene. Eur J Endocrinol 158 (2008) 417-422
21. Shaha A.R., Cohen T., Ghossein R., and Tuttle R.M. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members. Laryngoscope 116 (2006) 1704-1707
22. Lecube A., Hernandez C., Oriola J., Galard R., Gémar E., Mesa J., et al. V804 M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers. Surgery 131 (2002) 509-514
23. Miccoli P., Minuto M.N., Galleri D., D'Agostino J., Basolo F., Antonangeli L., et al. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. Aust N Z J Surg 76 (2006) 123-126
24. Recasens M., Oriola J., Fernández-Real J.M., Roig J., Rodríguez-Hermosa J.I., Font J.A., et al. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene. Clin Endocrinol (Oxf) 67 (2007) 29-33
25. Sippel R.S., Kunnimalaiyaan M., and Chen H. Current management of medullary thyroid cancer. Oncologist 13 (2008) 539-547